Evofem Presents Data Detailing Fewer Urinary Tract Infections in Women Using Phexxi in the Phase 3 AMPOWER Clinical Trial

Stock Information for Evofem Biosciences Inc.

Loading

Please wait while we load your information from QuoteMedia.